# Ernexa Therapeutics Inc.: Form 8-K, filed Mar 31, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2021-03-31
- Accepted by EDGAR: Mar 31, 2021, 17:18 ET
- Period: 2021-03-25
- Accession: 0001140361-21-011095
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036121011095/brhc10022537_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036121011095/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 3.03: Change to security holders’ rights
- Item 5.01: Change in control
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036121011095/brhc10022537_8k.htm

Filed Mar 31, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-011095. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.